Eli Lilly (LLY) Other Gross PP&E Adjustments (2009 - 2024)

Eli Lilly (LLY) has 16 years of Other Gross PP&E Adjustments data on file, last reported at $382.0 million in Q4 2024.

• For the quarter ending Q4 2024, Other Gross PP&E Adjustments rose 19.45% year-over-year to $382.0 million; the trailing twelve-month figure through Dec 2024 stood at $382.0 million (up 19.45% YoY), and the FY2024 full-year result was $382.0 million, up 19.45% from the prior year.
• Other Gross PP&E Adjustments for Q4 2024 stood at $382.0 million, up from $319.8 million in the prior quarter.
• Across five years, Other Gross PP&E Adjustments topped out at $382.0 million in Q4 2024 and bottomed at $226.8 million in Q4 2020.
• The 5-year median for Other Gross PP&E Adjustments is $258.7 million (2021), against an average of $288.8 million.
• The widest annual swing landed in 2020, when Other Gross PP&E Adjustments jumped 162.55%; it then fell 0.81% in 2022.
• A 5-year view of Other Gross PP&E Adjustments shows it stood at $226.8 million in 2020, then increased by 14.07% to $258.7 million in 2021, then dropped by 0.81% to $256.6 million in 2022, then rose by 24.63% to $319.8 million in 2023, then rose by 19.45% to $382.0 million in 2024.
• The last three Other Gross PP&E Adjustments figures came in at $382.0 million (Q4 2024), $319.8 million (Q4 2023), and $256.6 million (Q4 2022), per Business Quant data.

Peer Comparison